Products
Molecule name | Ingredients | Therapy | Innovator & Brand | Territories where the product is registered | Territories where the Product is under Registration | Future Target Market |
---|---|---|---|---|---|---|
Amlodipine tablets | Amlodipine Besylate | Anti-Hypertensive | Pfizer - Istin | Germany, Portugal, Austria, Spain, Ireland, Malta, Poland, UK |
Philippines, Vietnam | Canada, GCC, Australia, USA |
Azithromycin capsules | Azithromycin | Anti-infective | Pfizer- Zithroma | UK | Philippines | EU, Canada, Australia, GCC, USA |
Carbidopa + Levodopa ER tablets | Carbidopa and Levodopa | Parkinson's disease | Merck & Dohme– SINEMET CR Impax Laboratories –RYTARY |
- | - | EU, Canada and Australia |
Carbidopa + Levodopa IR tablets | Carbidopa and Levodopa | Parkinson's disease | Merck & Dohme– SINEMET Merck & Dohme– SINEMET PLUS |
Malta, UK, Czechia, Denmark, Canada, Australia, Germany, Spain, Poland, New Zealand |
Paraguay, Philippines, Myanmar, UK, Vietnam |
GCC, USA |
Cetirizine tablets | Cetirizine | Anti-histamine | UCB – ZYRTEC | Germany, Malta, Poland, Australia, Canada, UK |
Vietnam | GCC, USA |
Levocetirizine tablets | Levocetirizine | Anti-histamine | UCB – XYZAL | Germany, Poland, UK Malta, Portugal |
- | EU, Canada, Australia, GCC, UK, USA |
Olmesartan tablets | Olmesartan Medoxomil | Anti-Hypertension | Daiichi Sankyo – OLMETEC | - | Philippines, Myanmar, Vietnam | EU, Canada, Australia, GCC, UK, USA |
Olmesartan + HCTz tablets | Olmesartan Medoxomil and Hydrochlorothiazide | Anti-Hypertension | Daiichi Sankyo - Co Olmetec Daiichi Sankyo - Benicar HCT Daiichi Sankyo - Olmetec Plus |
- | Philippines, Myanmar, Vietnam | EU, Canada, Australia, GCC, UK, USA |
Raloxifene tablets | Raloxifene | Osteoporosis | Daiichi Sankyo – EVISTA | UK, Spain | Philippines, Vietnam | Canada, Australia, GCC, USA |
Telmisartan tablets | Telmisartan | Anti-Hypertension | Boehringer Ingelheim – MICARDIS | Australia, Ireland, UK, Malta, Czech Republic, Germany, Spain, Hungary, Netherlands, Poland, Romania, Slovakia, UK | Peru, Paraguay, Trinidad and Tobago, GCC | Canada, Australia, USA |
Telmisartan Amlodipine tablets | Telmisartan and Amlodipine Besylate | Anti-Hypertension | Boehringer Ingelheim – TWYNSTA | Australia | Philippines, Vietnam, Trinidad and Tobago, Peru, Myanmar | Canada, EU, GCC, UK, USA |
Telmisartan + HCTz tablets | Telmisartan and Hydrochlorothiazide | Anti-Hypertension | Boehringer Ingelheim - MICARDIS PLUS | Australia, Philippines, Vietnam | Trinidad and Tobago, Peru, Paraguay | Canada, EU, GCC, UK, USA |
Metformin IR tablets | Metformin IR | Anti-Diabetic | Merck - Glucopage | - | UK, Philippines | - |
Products in the pipeline
Molecule name | Ingredients | Therapy | Current Stage of Development | Dossier Availability |
---|---|---|---|---|
Clopidogrel tablets | Clopidogrel Bisulphate | Anti-Platelet | Process Validation batches in progress | Q1CY24 |
Hydroxyzine Hydrochloride tablets | Hydroxyzine Hydrochloride | Anti-Histamine | Process Validation batches in progress | Q1CY24 |
Montelukast + Levocetrizine tablets | Montelukast, Levocetirizine | Anti-Histamine | RND in progress | Q2CY24 |
Apixaban Tablet | Apixaban | Anti-Platelet | Complete dossier without BE study available, Bio study scheduled before December 2023 | Q1CY24 |
Dimethyl Fumarate Capsule | Dimethyl Fumarate | Immunomodulators | Complete dossier without BE study available, Bio study scheduled before December 2023 | Q1CY24 |